Charles Schwab Investment Management Inc Biolife Solutions Inc Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Biolife Solutions Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 319,959 shares of BLFS stock, worth $8.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

319,959

Previous 310,209 3.14%

Holding current value

$8.48 Million

Previous $6.65 Million 20.48%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$19.19 - $26.52 $187,102 - $258,570	9,750 Added 3.14%	319,959 $8.01 Million
Q2 2024 Aug 12, 2024	BUY	$15.14 - $22.99 $89,916 - $136,537	5,939 Added 1.95%	310,209 $6.65 Million
Q1 2024 May 08, 2024	BUY	$15.35 - $18.82 $293,891 - $360,327	19,146 Added 6.71%	304,270 $5.64 Million
Q4 2023 Feb 06, 2024	BUY	$8.99 - $16.86 $28,102 - $52,704	3,126 Added 1.11%	285,124 $4.63 Million
Q3 2023 Nov 08, 2023	BUY	$10.81 - $22.96 $181,110 - $384,671	16,754 Added 6.32%	281,998 $3.89 Million
Q2 2023 Aug 09, 2023	BUY	$17.19 - $24.34 $127,016 - $179,848	7,389 Added 2.87%	265,244 $5.86 Million
Q1 2023 May 11, 2023	BUY	$17.67 - $26.07 $68,718 - $101,386	3,889 Added 1.53%	257,855 $5.61 Million
Q4 2022 Feb 13, 2023	BUY	$16.95 - $25.07 $87,987 - $130,138	5,191 Added 2.09%	253,966 $4.62 Million
Q3 2022 Nov 14, 2022	BUY	$14.64 - $26.7 $337,861 - $616,182	23,078 Added 10.23%	248,775 $5.66 Million
Q2 2022 Aug 15, 2022	BUY	$10.54 - $24.2 $563,099 - $1.29 Million	53,425 Added 31.01%	225,697 $3.12 Million
Q1 2022 May 13, 2022	BUY	$20.81 - $37.29 $137,928 - $247,158	6,628 Added 4.0%	172,272 $3.92 Million
Q4 2021 Feb 11, 2022	SELL	$32.99 - $58.55 $904,882 - $1.61 Million	-27,429 Reduced 14.21%	165,644 $6.17 Million
Q3 2021 Nov 16, 2021	SELL	$42.03 - $60.5 $424,713 - $611,352	-10,105 Reduced 4.97%	193,073 $8.17 Million
Q2 2021 Aug 16, 2021	BUY	$29.51 - $44.62 $1.59 Million - $2.41 Million	54,000 Added 36.2%	203,178 $9.04 Million
Q1 2021 May 17, 2021	BUY	$32.95 - $44.24 $179,280 - $240,709	5,441 Added 3.79%	149,178 $5.37 Million
Q4 2020 Feb 16, 2021	BUY	$27.5 - $45.75 $144,650 - $240,645	5,260 Added 3.8%	143,737 $5.73 Million
Q3 2020 Nov 13, 2020	BUY	$16.04 - $28.94 $1.86 Million - $3.36 Million	116,108 Added 519.06%	138,477 $4.01 Million
Q2 2020 Aug 14, 2020	BUY	$9.2 - $17.06 $36,533 - $67,745	3,971 Added 21.58%	22,369 $366,000
Q4 2019 Feb 07, 2020	BUY	$14.59 - $18.9 $20,455 - $26,497	1,402 Added 8.25%	18,398 $298,000
Q3 2019 Nov 08, 2019	BUY	$15.7 - $20.98 $4,819 - $6,440	307 Added 1.84%	16,996 $283,000
Q2 2019 Aug 09, 2019	BUY	$15.2 - $19.42 $253,672 - $324,100	16,689 New	16,689 $283,000

Others Institutions Holding BLFS

# of Institutions

198

Shares Held

44.9M

Call Options Held

8.2K

Put Options Held

View Full List

About BIOLIFE SOLUTIONS INC

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.13B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

More about BLFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Biolife Solutions Inc Transaction History